LOA provides consulting services across the full spectrum of oncology drug development — from early scientific strategy through late-stage clinical execution and business development.
LOA takes pride in helping companies focus their strategy to maximize chances of success with the highest efficiency and lowest cost. We develop the optimal clinical development plan with the appropriate pre-clinical strategy to support it, and identify key value inflection points that may be achieved in minimum time and at lowest expenditure. We also support Life Cycle Management for companies proceeding into advanced development.
Extensive clinical development expertise in academic, cooperative group, start-up, small biotech, small pharma, and Big Pharma environments. Having both the academic and commercial perspectives, as well as a strong translational research background, allows us to design cutting-edge clinical protocols and development plans that take into account all appropriate stakeholders.
Aside from work in Clinical Development, Business Development, and Strategy, LOA also helps identify potential funding for small biotechnology and biomedical companies through contacts in the investment community.
An extensive scientific and clinical research background provides for expert assessment of products and companies for pharmaceutical licensing and M&A. Experience developed over the years has led to interaction with many VCs and pharmaceutical companies, allowing us to match and introduce potential partners and facilitate deal-making.
Extensive experience in both medical and radiation oncology, combined with academic and commercial expertise, provides a broad background for drug development. Deep interactions with other aspects of drug development — Commercial, IP, Regulatory, Sales and Marketing, Operations, and Management — provide depth and breadth to our perspective and approach. The results are an optimal package for drug development.
As a Board Certified Internist (ABIM and Israel), Dr. Levitt is well positioned to provide a far-ranging vision for the development of a product, beyond its applications in oncology. This can add significant value and attractiveness to a product under development.
LOA also performs Search and Evaluation functions within the vibrant Israeli biotechnology sector — identifying and evaluating innovative Israeli companies for international partners. Due to the nature of consulting work, much of LOA's most significant work remains confidential. For more information on specific capabilities, please get in touch directly.